Angela R. Wateska

When models diverge: Harmonizing pneumococcal vaccination cost-effectiveness analyses to inform PCV20 and PCV21 use in US adults

Objectives Policymakers use decision models to assess pneumococcal vaccine cost-effectiveness, but different models often yield inconsistent results. We systematically compared 2 published models evaluating 20- and 21-valent pneumococcal conjugate vaccines (PCV20/PCV21) in adults...